Stories

The UK’s smoking rate falling below one in ten is a milestone worth protecting. It has happened alongside wider use of smoke-free nicotine products, which makes upcoming pouch restrictions especially important to get right. Age limits can help prevent youth access, but they should not blur the role pouches may play for adults looking for alternatives to cigarettes. The next phase of UK policy should keep the focus on the outcome that matters most: fewer people smoking.

Banning products before they even exist is not precaution; it is policy closing its eyes to innovation. Eight EU capitals pushing restrictions on future nicotine products risk freezing the market around what already exists, including cigarettes. New products should face evidence, standards and scrutiny, not pre-emptive exclusion based on category fear. A smarter European approach would regulate risk as it emerges, while keeping the door open to technologies that could help move smokers further away from combustion.

Vape tax needs watching because small price changes can become big behaviour changes. For adults who have switched from smoking, affordability can help keep the lower-risk option within reach; for those still smoking, it can influence whether switching feels realistic at all. A poorly calibrated tax may push people back towards cigarettes or towards cheaper illicit products. The test should be simple: does the policy keep movement away from combustion attractive, or does it make that progress harder to sustain?

The FDA review backlog is not just an administrative problem; it shapes the market smokers actually face. Legal smoke-free products wait in uncertainty, while illicit and unapproved products move faster than the system designed to regulate them. That imbalance leaves adult smokers with fewer accountable options and gives the black market more space to grow. Product review should be rigorous, but it also has to be timely enough to support harm reduction in the real world.

A snapshot can show where nicotine use is at one moment, but it cannot explain the whole journey. Smoking, vaping and switching are dynamic behaviours, shaped by timing, motivation, access and whether people move fully away from cigarettes. Treating one data point as a final verdict risks missing the direction of change that matters most for harm reduction. Better analysis follows the pathway, not just the photograph.

New Zealand’s progress shows what tobacco policy can look like when harm reduction is treated as part of the solution. Smoking has fallen alongside access to vaping, suggesting that lower-risk alternatives can help accelerate the move away from combustion when smokers are given practical options. The lesson is not that regulation should disappear, but that it should support the direction of change already reducing harm. Public health should learn from countries where smoking is falling fastest, not dismiss the tools helping make it happen.

A reset of the FDA’s PMTA process is overdue if regulation is meant to guide the market rather than paralyse it. The current pathway has left many smoke-free products trapped in uncertainty while cigarettes remain legally available and illicit alternatives gain space. A better system should be rigorous, transparent and fast enough to distinguish responsible products from those that do not meet standards. Harm reduction depends on regulation that can make timely decisions, not one that delays safer options out of reach.

The new GSTHR briefing paper focuses on a shift that is already happening: people moving from cigarettes to safer nicotine products. These transitions are not theoretical policy models; they can be seen across countries where vapes, pouches, snus and heated tobacco products are changing patterns of nicotine use. That matters because the public health gain comes from reducing exposure to combustion, even when nicotine use continues. Regulation should understand these pathways before it disrupts them.

Australia’s nicotine policy is drifting further from the reality consumers are living in. Cigarettes remain legal, illicit tobacco is expanding, and many vapers are navigating workarounds, informal supply or rules that do not match how people actually quit smoking. That gap matters because policy cannot reduce harm effectively while pretending demand has disappeared or that restriction equals control. A better approach would start from real behaviour: keep people inside legal channels, make safer alternatives accessible, and measure success by fewer people smoking.

Europe’s nicotine debate is becoming a house divided. Some countries are moving towards risk-proportionate regulation, while others are pushing bans, higher taxes and restrictions that may leave cigarettes in a stronger position. That split matters because smokers across Europe are not facing the same chances to move away from combustion. A coherent EU strategy should protect young people, recognise product differences and make the lower-risk route easier to take than the deadly one.